Cargando…

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).

Detalles Bibliográficos
Autores principales:	Dorey, E. L., Outram, S. V., Holder, A., Rohatiner, A. Z., Cotter, F. E., Deane, M., Stansfeld, A. G., Lister, T. A., Horton, M. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247209/ https://www.ncbi.nlm.nih.gov/pubmed/2472166

Ejemplares similares

Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
por: Rohatiner, A. Z., et al.
Publicado: (1987)

Non-Hodgkin Lymphoma (NHL) in Pakistan
por: Pervez, Shahid
Publicado: (2012)

BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
por: Butler, M., et al.
Publicado: (1997)

Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma.
por: Whelan, J. S., et al.
Publicado: (1991)

Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report
por: Loves, Sandra SCM, et al.
Publicado: (2006)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk
por: De Roos, Anneclaire J, et al.
Publicado: (2022)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations
por: Bradshaw, Gabrielle, et al.
Publicado: (2019)

Correlation of Patterns of Bone Marrow Infiltration and Biochemical factors in Non-Hodgkin Lymphoma
por: Mazher, Naghmana, et al.
Publicado: (2017)

Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study
por: Wheeler, David C, et al.
Publicado: (2011)

NHL - Extranodal T-cell lymphoma
por: Devi, Seema, et al.
Publicado: (2015)

Survival among AIDS patients with and without non-Hodgkin's lymphoma, and NHL-HIV-negative patients
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2007)

Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study
por: Czarnota, Jenna, et al.
Publicado: (2015)

Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects
por: McDuffie, Helen H, et al.
Publicado: (2009)

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993)

Bone marrow infiltration of lymphoma
por: Kim, Ki Hwan, et al.
Publicado: (2010)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
por: Ghassemi, Ali, et al.
Publicado: (2016)

Bone marrow involvement by classic Hodgkin lymphoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin’s Lymphomas
por: Veryaskina, Yuliya A., et al.
Publicado: (2022)

Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
por: Beachler, Dan, et al.
Publicado: (2010)

Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)
por: Eraslan, Zuhal, et al.
Publicado: (2021)

Mediastinal large-cell lymphoma with sclerosis (MLCLS).
por: Rohatiner, A. Z., et al.
Publicado: (1994)

Bone marrow involvement by classic Hodgkin lymphoma posttransplant lymphoproliferative disorder
por: Lyapichev, Kirill A., et al.
Publicado: (2021)

SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression
por: Ten, Lik-Chin, et al.
Publicado: (2017)

In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin’s lymphoma (NHL)
por: Aya-Bonilla, Carlos, et al.
Publicado: (2014)

Immunocompetent Patient With Primary Bone Marrow Hodgkin Lymphoma
por: Dhaliwal, Armaan, et al.
Publicado: (2022)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study
por: Anargyrou, Konstantinos, et al.
Publicado: (2019)

Innate Immunity and Non-Hodgkin’s Lymphoma (NHL) Related Genes in a Nested Case-Control Study for Gastric Cancer Risk
por: Park, Sue K., et al.
Publicado: (2012)

A case report of surgical management of a solitary Non-Hodgkin's Lymphoma (NHL) arising from the proximal sciatic nerve
por: Gobinath, Sivakumaran, et al.
Publicado: (2023)

Primary non-Hodgkin’s Lymphoma of the Bladder with Bone Marrow Involvement
por: Oh, Kil Chan, et al.
Publicado: (2003)

Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
por: Habeshaw, J. A., et al.
Publicado: (1979)

Lymphoid Infiltrates in B Cell Non Hodgkin’s Lymphoma: Comparing Nuclear Characteristics between Lymph Node and Bone Marrow; and Evaluating Diagnostic Features of Bone Marrow Infiltrates in Paraffin Embedded Tissues
por: Deverell, Mark H., et al.
Publicado: (1997)

Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
por: Dorreen, M. S., et al.
Publicado: (1984)

Biomarkers in NHL
por: Malek, Sami N.
Publicado: (2011)

The TRIM-NHL protein NHL-2 is a co-factor in the nuclear and somatic RNAi pathways in C. elegans
por: Davis, Gregory M, et al.
Publicado: (2018)

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL
por: Zinzani, P. L., et al.
Publicado: (2022)

Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study
por: Link, Hartmut, et al.
Publicado: (2020)

Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment
por: Epeldegui, Marta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_792nummq7oge262sr4klgrh9tv